title: [Atrial fibrillation: current therapeutic options].
abstract: The treatment of atrial fibrillation still remains challenging in everyday practice. Even after the introduction of catheter ablation, the decision making about the type of therapy became more complex. The recently published guidelines of the American Heart Association, the American College of Cardiology, and the European Society of Cardiology clearly show therapeutic approaches for different types of atrial fibrillation. The fear of thromboembolism still forces the physician to restore sinus rhythms and perform a perfect anticoagulation. Based on large studies, we are able to decide for each patient individually whether oral anticoagulation or acetylsalicylic acid/clopidogrel are required. Future studies in a large cohort of patients are still necessary to clarify the value of interventional therapy in conjunction with antiarrhythmic drug therapy. These will provide patients with a safe therapy and high quality of life despite presenting paroxysmal or persistent atrial fibrillation.
authors.affiliation: Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn. b.luederitz@uni-bonn.de
authors.forename: Berndt
authors.initials: B
authors.lastname: Lüderitz
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D004554:Electric Countershock; D004562:Electrocardiography / Q000187:drug effects; D005858:Germany; D006801:Humans; D017410:Practice Guidelines as Topic; D055502:Secondary Prevention
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants